pharmaceuticals
pharmaceuticals Articles
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
Published:
Last Updated:
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into...
Published:
Last Updated:
TiGenix intends to offer more than 2 million American depositary shares in its initial public offering and to list on the Nasdaq.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
Published:
Last Updated:
A series of new Jefferies reports focus on four biotech stocks that have big upside potential, regardless of the political chatter.
Published:
Last Updated:
Clearside Biomedical now expects to price its 4 million shares at $9.00 per share for a secondary offering valued up to more than $41 million.
Published:
Last Updated:
Around noon on Thursday, short-seller Citron Research offered some free advice to President-Elect Donald Trump: If Trump is serious about cutting prescription drug costs, go after Express Scripts.
Published:
Last Updated:
Recro Pharma intends to offer more than 5 million shares at $6.99 apiece in a secondary offering valued at roughly $40 million.
Published:
Last Updated:
Horizon Pharma PLC saw its shares take a big step back on Thursday after the company reported topline results from one of its late-stage trials.
Published:
Last Updated:
Clearside Biomedical expects to price nearly 5 million shares at $15.18 per share in a secondary offering valued up to more than $86 million.
Published:
Last Updated:
Trump told Time that he wants to lower drug prices, a move that has hit the drug and biotech segments due to his comments.
Published:
Last Updated:
Repros Therapeutics saw its shares take a loss on Wednesday after the company provided a key FDA update.
Published:
Last Updated:
TiGenix has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Teva Pharmaceutical Industries shares sank on Tuesday after the company announced the appointment of Dipankar Bhattacharjee as chief executive for its global generic medicines group.
Published:
Last Updated:
Reata Pharmaceuticals has filed an S-1 form with the U.S. Securities and Exchange Commission for a secondary offering.
Published:
Last Updated: